review of a 5 year clinical experience with the histamine h2-receptor antagonists metiamide , cimetidine , and ranitidine in 20 patients with zollinger-ellison syndrome disclosed a treatment failure rate of 50 percent .
C0008783
cimetidine
C0043515
zollinger-ellison syndrome